GE HealthCare and non-profit health system Ascension have partnered to improve clinical and operational outcomes within the latter’s national network.
This partnership is set to enhance access and experience of patients, aligning with Ascension’s mission to serve everyone, particularly the vulnerable and poor.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It will utilise GE HealthCare’s portfolio of technologies across various modalities, including magnetic resonance (MR), nuclear medicine, computed tomography (CT), X-ray, and ultrasound, in areas such as general imaging, cardiovascular, women’s health, and point of care.
The alliance is expected to offer access to the latest imaging technology, potentially reducing scan times, wait times for care, and improving diagnostic accuracy.
This agreement signifies a continuation of the longstanding connection between Ascension Health and GE HealthCare.
Both organisations aim to explore further opportunities to progress patient care and access, especially in the main markets.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAscension’s operations include 30 senior living facilities and various other care sites that provide a range of healthcare services.
Ascension president Eduardo Conrado said: “GE HealthCare brings advanced technology and expertise that make a real difference for our patients and our teams.
“Together, we are taking important steps to improve care, drive new solutions, and deliver better results for the people who rely on us. This partnership is also about shaping the future of healthcare—making sure our caregivers are equipped with the right technology, in the right place, at the right time, so we can deliver better care for all.”
Last month, GE HealthCare renewed its research partnership with Stanford Medicine in the US, focusing on the advancement of total body positron emission tomography (PET) / CT technology.
The company also introduced software that integrates its imaging functionalities with tools from a platform developed by MIM Software, aiming to optimise imaging workflows in fields such as oncology and cardiology.
